$1.76Billion– No. of Holdings #26
| Ticker | $ Bought |
|---|---|
| spyglass pharma, inc. | 191,535,000 |
| Ticker | % Inc. |
|---|---|
| korro bio, inc. | 18.99 |
| zenas biopharma, inc. | 14.19 |
| Ticker | % Reduced |
|---|---|
| gossamer bio, inc. | -94.47 |
| celcuity inc. | -35.36 |
| Ticker | $ Sold |
|---|---|
| synlogic, inc. | -3,273,500 |
| rhythm pharmaceuticals, inc. | -311,482,000 |
NEA Management Company, LLC has about 72.8% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 72.8 |
| Others | 22.9 |
| Consumer Defensive | 4.3 |
NEA Management Company, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 37.6 |
| SMALL-CAP | 35.6 |
| UNALLOCATED | 22.9 |
| MICRO-CAP | 3.4 |
About 72.6% of the stocks held by NEA Management Company, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 72.6 |
| Others | 27.4 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
NEA Management Company, LLC has 26 stocks in it's portfolio. About 87.6% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. ACLX was the most profitable stock for NEA Management Company, LLC last quarter.
Last Reported on: 15 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACLX | arcellx, inc. | 19.88 | 3,045,260 | 349,657,000 | unchanged | 0.00 | ||
| ATHA | leonabio, inc. | 0.27 | 46,908 | 4,774,010 | unchanged | 0.00 | ||
| AUPH | aurinia pharmaceuticals, inc. | 3.34 | 3,969,830 | 58,832,900 | unchanged | 0.00 | ||
| BDTX | black diamond therapeutics, inc. | 0.54 | 4,448,760 | 9,475,850 | unchanged | 0.00 | ||
| CELC | celcuity inc. | 14.83 | 2,285,560 | 260,874,000 | reduced | -35.36 | ||
| COUR | coursera, inc. | 4.26 | 12,867,800 | 74,890,400 | unchanged | 0.00 | ||
| CRSP | crispr therapeutics ag | 2.86 | 1,058,570 | 50,356,200 | unchanged | 0.00 | ||
| CSBR | champions oncology, inc. | 0.56 | 1,713,720 | 9,853,890 | unchanged | 0.00 | ||
| CVRX | cvrx, inc. | 1.09 | 2,026,080 | 19,166,700 | unchanged | 0.00 | ||
| GLUE | monte rosa therapeutics, inc. | 7.19 | 7,692,300 | 126,538,000 | unchanged | 0.00 | ||
| GOSS | gossamer bio, inc. | 0.02 | 1,000,000 | 328,500 | reduced | -94.47 | ||
| IKNA | imagenebio, inc. | 0.01 | 50,005 | 250,025 | unchanged | 0.00 | ||
| IVA | inventiva sa | 0.46 | 1,462,590 | 8,029,600 | unchanged | 0.00 | ||
| MRKR | marker therapeutics, inc. | 0.12 | 1,625,680 | 2,113,380 | unchanged | 0.00 | ||
| NKTX | nkarta, inc. | 0.43 | 3,568,780 | 7,530,130 | unchanged | 0.00 | ||
| ORIC | oric pharmaceuticals, inc. | 2.97 | 4,118,620 | 52,182,900 | unchanged | 0.00 | ||
| PHAT | phathom pharmaceuticals, inc. | 1.24 | 1,960,170 | 21,777,500 | unchanged | 0.00 | ||
| RYTM | rhythm pharmaceuticals, inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| SNTI | senti biosciences, inc. | 0.17 | 3,775,620 | 3,065,800 | unchanged | 0.00 | ||
| SVRA | savara, inc. | 7.60 | 24,471,300 | 133,613,000 | unchanged | 0.00 | ||